Capital Analysts LLC’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Capital Analysts LLC’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,500	Closed	-$105K	–	746
2020 Q3	$105K	Hold	1,500	–	–	0.01%	307
2020 Q2	$109K	Hold	1,500	–	–	0.01%	270
2020 Q1	$69K	Hold	1,500	–	–	0.01%	294
2019 Q4	$93K	Sell	1,500 -230	-13%	-$12.3K	0.01%	307
2019 Q3	$73K	Hold	1,730	–	–	0.01%	325
2019 Q2	$90K	Hold	1,730	–	–	0.01%	288
2019 Q1	$95K	Hold	1,730	–	–	0.01%	268
2018 Q4	$73K	Hold	1,730	–	–	0.01%	262
2018 Q3	$121K	Hold	1,730	–	–	0.01%	232
2018 Q2	$99K	Hold	1,730	–	–	0.01%	248
2018 Q1	$95K	Hold	1,730	–	–	0.01%	249
2017 Q4	$97K	Hold	1,730	–	–	0.01%	243
2017 Q3	$106K	Hold	1,730	–	–	0.01%	236
2017 Q2	$92.4K	Hold	1,730	–	–	0.01%	250
2017 Q1	$83.5K	Hold	1,730	–	–	0.01%	228
2016 Q4	$69K	Hold	1,730	–	–	0.01%	251
2016 Q3	$83.8K	Buy	+1,730	New	+$82.2K	0.02%	220
2016 Q2	–	Sell	-1,730	Closed	-$70.7K	–	333
2016 Q1	$70.7K	Hold	1,730	–	–	0.01%	242
2015 Q4	$124K	Hold	1,730	–	–	0.03%	197
2015 Q3	$101K	Hold	1,730	–	–	0.02%	228
2015 Q2	$156K	Hold	1,730	–	–	0.03%	187
2015 Q1	$137K	Hold	1,730	–	–	0.03%	183
2014 Q4	$109K	Hold	1,730	–	–	0.02%	189
2014 Q3	$89.9K	Hold	1,730	–	–	0.02%	198
2014 Q2	$80.3K	Hold	1,730	–	–	0.02%	197
2014 Q1	$69.1K	Buy	+1,730	New	+$78.5K	0.02%	204

Other funds holding BIB

Sowell Financial Services North Little Rock, Arkansas $3.61B AUM 22.22% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Chase Investment Counsel Charlottesville, Virginia $474M AUM 95.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

UMC

United Maritime Capital New York $15.2M AUM 45.42% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $38.6B AUM 35.31% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Capital Analysts LLC's BIB Position: Q4 2020 in Review

Capital Analysts LLC sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q4 2020, closing a stake of 1,500 shares — an estimated $105K sold.

Capital Analysts LLC first reported a position in BIB in Q1 2014 and held it in 26 quarters. The position peaked at $156K in Q2 2015. 34 funds tracked by Wall St. Rank hold BIB as of Q4 2020.

Capital Analysts LLC reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q4 2020 after selling out during the quarter.
Capital Analysts LLC sold 1,500 ProShares Ultra NASDAQ Biotechnology shares in Q4 2020, an estimated $105K.
Capital Analysts LLC first reported a position in ProShares Ultra NASDAQ Biotechnology in Q1 2014 and held it in 26 quarters.
Capital Analysts LLC's ProShares Ultra NASDAQ Biotechnology position peaked at $156K in Q2 2015.
34 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2020.

Based on Capital Analysts LLC's 13F filing for Q4 2020, filed 16 Feb 2021.